Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2015 (2015), Article ID 707254, 7 pages
http://dx.doi.org/10.1155/2015/707254
Research Article

Serum Cytokine of IL-10 and IL-12 in Chronic Liver Disease: The Immune and Inflammatory Response

1Gastroenterology Laboratories, Gastroenterology Surgical Center, Mansoura University, Mansoura 35516, Egypt
2Molecular Biology Department, Genetic Engineering and Biotechnology Research Institute, Sadat University, Sadat City, Egypt
3Biochemistry Department, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia
4Pathology Department, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt

Received 5 October 2015; Revised 12 November 2015; Accepted 23 November 2015

Academic Editor: Leigh A. Madden

Copyright © 2015 Hoda Mohamed El-Emshaty et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

The current study was designed to investigate the potential association of serum interleukin-10 and interleukin-12 with HCV infection in chronic liver disease and to evaluate their possible role as new biomarkers in HCC development. Material and Methods. Forty-one patients suffering from chronic liver disease (33 patients harbor HCV infection and 8 are HCV-negative patients) were enrolled in the present study and histopathologically diagnosed into 15 patients with HCC, 16 patients with LC, and 10 patients with liver histology compatible with precirrhotic hepatitis (PCH). Ten patients complaining of cholecystitis were included as nondisease control. Serum levels of IL-10 and IL-12 were measured by enzyme linked immunosorbent assay (ELISA). Results. HCV-infected patients showed elevated expression of IL-10 and IL-12 compared to nondisease controls () but there is no significant difference with respect to their expression in HCV-negative patients. Serum IL-10 and IL-12 were elevated significantly with disease progression () and a positive correlation coefficient was detected between IL-10, IL-12 (, ), and transaminase values suggesting their possible role in chronic inflammation progression leading to HCC. Conclusion. IL-10 and IL-12 might be involved in chronic inflammation progression leading to HCC and their evaluation could be used as new biomarkers to reflect the degree of inflammation in HCC development.